Abstract
Diffuse interstitial lung disease (DILD) is a heterogeneous group of lung disorders characterised histologically by diffuse inflammation and fibrosis affecting predominantly, but not exclusively, the pulmonary interstitium. Fundamental points for diagnosis: Previously identified DILD: eliminate pulmonary infection (intracellular and opportunistic pathogens, viruses), pulmonary embolus, pneumothorax, cardiogenic involvement, drug-associated toxicity and carcinomatous lymphangitis before concluding that it is an exacerbation of pulmonary fibrosis. The key examinations are high-definition (HD)-thoracic TDM, bronchoalveolar lavage (BAL), microbiological specimens and echocardiography. In the case of previous severe restrictive respiratory failure, the prognosis is extremely poor.
Previously unknown DILD: look for infectious pneumonia (intracellular pathogens, Pneumocystis, viruses), connective tissue disease, granulomatosis, cancer, drug- or environment-associated toxicity, before concluding an idiopathic cause. The key examinations are extrapulmonary signs, HD-thoracic TDM, BAL, microbiological specimens and immunological investigations. A lung biopsy may be carried out if no diagnosis is made and is contributory in >65 % of cases. Fundamental points for treatment: Non-invasive ventilation is rarely effective, but can help in carrying out BAL. Invasive ventilation should be protective. Antibiotic treatment (consider anti-intracellular pathogens, Pneumocystis) is usually prescribed in view of the high frequency and good prognosis of infectious aetiologies. Corticotherapy has poor efficacy outside connective tissue diseases and granulomatosis, eosinophilic pneumonia, histiocytosis and cryptogenic organising pneumonia. The prognosis is extremely poor in patients with established pulmonary fibrosis. In this situation, palliative care should be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Talmadge KE (2008) Interstitial lung diseases. In: Fauci AS, Braunwald E, Kasper DL et al (eds) Harrison’s principles of internal medicine, 17th edn. McGraw Hill, New York
Cottin V, Thivolet-Béjui F, Cordier J-F (2006) Pneumopathies interstitielles diffuses idiopathiques. EMC (Elsevier SAS, Paris) Pneumologie 6-039-K-70
Afshar K, Sharma OP (2008) Interstitial lung disease: trials and tribulations. Curr Opin Pulm Med 14:427–433
Mallick S (2008) Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit. Respir Med 102:1355–1359
Fumeaux T, Rothmeier C, Jolliet P (2003) Les fibroses pulmonaires en réanimation. Réanimation 12:37–45
Raghu G, Collard HR, Egan JJ et al (2011) ATS/ERS/JRS/ALAT committee on idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824
Güngör G, Tatar D, Saltürk C et al (2012) Why do patients with interstitial lung diseases fail in the ICU?: A two-center cohort study. Respir Care Aug 16 [Epub ahead of print]
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Forel, JM., Gomez, C., Hraiech, S., Chiche, L. (2014). Diffuse Interstitial Lung Disease and Pulmonary Fibrosis. In: Leone, M., Martin, C., Vincent, JL. (eds) Uncommon Diseases in the ICU. Springer, Cham. https://doi.org/10.1007/978-3-319-04576-4_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-04576-4_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-04575-7
Online ISBN: 978-3-319-04576-4
eBook Packages: MedicineMedicine (R0)